SCHEMBL15443951

SCHEMBL15443951

Nc1ccc(-c2nc3cc4[nH]c(-c5ccc(N)cc5)nc4cc3[nH]2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 0.79
KMT2A Q03164 11/20 0.79
ALDH1A1 P00352 11/20 0.79
MAPT P10636 11/20 0.79
SMN1; SMN2 Q16637 9/20 0.79
KDM4E B2RXH2 9/20 0.79
NPC1 O15118 9/20 0.79
GAA P10253 9/20 0.79
RAB9A P51151 8/20 0.79
GLA P06280 5/20 0.79
GFER P55789 5/20 0.79
RXFP1 Q9HBX9 3/20 0.79
RECQL P46063 2/20 0.79
CACNA1B Q00975 2/20 0.76
APBA1 Q02410 2/20 0.76
HPGD P15428 9/20 0.74
POLB P06746 8/20 0.74
HSD17B10 Q99714 4/20 0.74
BLM P54132 4/20 0.74
NFKB1 P19838 3/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15443910 0.94 MEN1 (0.77) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL15443953 0.89 MEN1 (0.87) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL28312335 0.89 ALDH1A1 (0.74) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL363703 0.89 MEN1 (1.00) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL9862039 0.89 ALDH1A1 (0.69) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL159873 0.89 ALDH1A1 (0.74) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL30307784 0.89 ALDH1A1 (0.74) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL15443952 0.88 PRMT1 (0.75) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL38658270 0.88 ALDH1A1 (0.69) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL6325549 0.88 ALDH1A1 (0.68) MEN1KMT2AALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140066629-A1 PROCESS FOR THE PREPARATION OF AROMATIC AZOLE COMPOUNDS E I DU PONT DE NEMOURS AND COMPANY (US) 2014-03-06 US disclosed
US-20140066629-A1 PROCESS FOR THE PREPARATION OF AROMATIC AZOLE COMPOUNDS E I DU PONT DE NEMOURS AND COMPANY (US) 2014-03-06 US disclosed
US-20140066629-A1 PROCESS FOR THE PREPARATION OF AROMATIC AZOLE COMPOUNDS E I DU PONT DE NEMOURS AND COMPANY (US) 2014-03-06 US disclosed
US-20140024753-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT CHI MEI CORPORATION (TW) 2014-01-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140066629-A1 PROCESS FOR THE PREPARATION OF AROMATIC AZOLE COMPOUNDS PAH, PNPO, ARSA MEN1 3634/4885KMT2A 1569/4885ALDH1A1 2653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.